Patent Assignment
Reel/Frame 053172/0344
Merger
Recorded: 2020-07-10
Pages: 9
Assignor
TOLERO PHARMACEUTICALS, INC.
Executed: 2020-07-01
Assignee
BOSTON BIOMEDICAL, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(10)
Methods for Treating Diseases Associated with Abnormal ACVR1 Expression and ACVR1 Inhibitors for Use in the Same
PCT:
PCT/US2019/043738 ↗
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
PCT:
PCT/US2020/013214 ↗
JAK2 and ALK2 Inhibitors and Methods for Their Use
JAK2 and ALK2 Inhibitors and Methods for Their Use
Methods for Treating Diseases Associated with Abnormal ACVR1 Expression and ACVR1 Inhibitors for Use in the Same
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
Application:
16/740,219 →
Publication:
US 2020/0323851
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application:
61/785,460 →
Methods for Treating Diseases Associated with Abnormal ACVR1 Expression and ACVR1 Inhibitors for Use in the Same
Application:
62/703,862 →
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
Application:
62/790,961 →
Solid Dose Pharmaceutical Composition
Application:
62/939,489 →
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 31, 2013
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 030914/0054 →
Assignment of Assignor's Interest
Mar 22, 2016
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 038068/0314 →
Security Interest
Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Assignment of Assignor's Interest
Oct 19, 2018
From: WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 047238/0796 →
Assignment of Assignor's Interest
Jul 24, 2019
From: BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049842/0561 →
Assignment of Assignor's Interest
Jul 24, 2019
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049842/0192 →
Assignment of Assignor's Interest
Oct 3, 2019
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050612/0176 →
Assignment of Assignor's Interest
Oct 3, 2019
From: WARNER, STEVEN L.; BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050611/0952 →
Assignment of Assignor's Interest
Oct 3, 2019
From: ARIKAWA, YUKA
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 050612/0115 →
Assignment of Assignor's Interest
Oct 3, 2019
From: WARNER, STEVEN L.; BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050612/0260 →
Assignment of Assignor's Interest
Oct 3, 2019
From: ARIKAWA, YUKA
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 050612/0386 →
Assignment of Assignor's Interest
Oct 3, 2019
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050612/0563 →
Assignment of Assignor's Interest
Jan 15, 2020
From: WARNER, STEVEN L.; FOULKS, JASON MARC; FLYNN, PAUL
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051524/0130 →
Assignment of Assignor's Interest
Jan 24, 2020
From: BEARSS, DAVID J.; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051613/0030 →
Assignment of Assignor's Interest
Jun 30, 2020
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 053091/0872 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0663 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger
Oct 23, 2023
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 065314/0430 →
Merger
Oct 27, 2023
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 065377/0580 →